Reflux Testing Devices Market Size
Reflux Testing Devices Market was valued at USD 3.2 billion in 2022 and is estimated to account for USD 5 billion by 2032 driven by the increasing prevalence of gastroesophageal reflux disease (GERD). Lifestyle changes, dietary habits, and an aging population base have contributed to the rising number of individuals experiencing GERD-related symptoms, such as heartburn and regurgitation. As awareness of the potential complications of untreated GERD grows among patients and healthcare providers, there is a heightened demand for accurate diagnostic tools and monitoring devices.

As our population ages, more and more people are struggling with a condition called GERD (gastroesophageal reflux disease). It's a common problem that affects nearly 11 million people over the age of 65—that's 19% of that age group. And over the next decade, that number is expected to grow to around 13 million, or 22% of seniors. This rise in the number of older adults is creating a growing need for devices that can help diagnose and monitor GERD. That's because GERD is a condition that can have serious consequences if left untreated. And as people get older, they're more likely to develop GERD. There are a few reasons why older people are more likely to develop GERD. One reason is that the digestive tract changes as we age. These changes can make it more difficult for the stomach to empty properly, which can lead to acid reflux. Another reason is that older people are more likely to have other health conditions, such as diabetes or arthritis, that can increase the risk of GERD. As a result of these factors, there is a growing demand for accurate diagnostic tools and monitoring systems that can help evaluate the severity of GERD and guide treatment decisions. These devices can help ensure that older adults with GERD receive the treatment they need to manage their condition and avoid serious complications.
Reflux Testing Devices Market Report Attributes
Report Attribute |
Details |
Base Year | 2022 |
---|
Reflux Testing Devices Market Size in 2022 | USD 3.2 Billion |
---|
Forecast Period | 2023 to 2032 |
---|
Forecast Period 2023 to 2032 CAGR | 4.7% |
---|
2032 Value Projection | USD 5 Billion |
---|
Historical Data for | 2018 to 2022 |
---|
No. of Pages | 154 |
---|
Tables, Charts & Figures | 345 |
Segments covered | Product Type, Application, End-use, and Region |
---|
Growth Drivers | - Increasing prevalence of gastroesophageal reflux disease (GERD)
- Growing awareness and diagnosis rates
- Increasing shift towards minimally invasive procedures
- Technological advancements
|
---|
Pitfalls & Challenges | - Limited awareness and underdiagnosis
- Availability of alternative treatment approaches
|
---|
COVID-19 Impact
The COVID-19 pandemic really put a damper on the demand for devices used to test for acid reflux. With lockdowns, travel restrictions, and people tightening their belts, fewer folks were going for elective medical procedures like reflux tests. During the height of the pandemic, hospitals were understandably focused on fighting the virus, so they had to postpone or cancel non-urgent surgeries and tests. As a result, there was a dip in the need for reflux testing equipment. To make matters worse, COVID-19 primarily affects the lungs, so hospitals and clinics everywhere were pouring their resources into testing for respiratory problems. This meant that gastrointestinal issues like acid reflux might have taken a backseat for a while, further reducing the need for reflux tests.
Reflux Testing Devices Market Trends
GERD is no longer a rare affliction; it is a widespread condition affecting a substantial portion of the population. In the U.S. alone, GERD is estimated to affect over 20% of adults regularly, with millions experiencing symptoms intermittently. Globally, GERD’s prevalence is on the rise and is one of the driving forces behind the surge in GERD diagnosis. For instance, a study published in the Journal of Gastroenterology and Hepatology found that 63% of respondents were familiar with GERD symptoms, indicating improved public awareness.
Furthermore, people are more informed than ever about GERD’s signs and symptoms, through an abundance of information available online and through healthcare providers. Public health campaigns, medical literature, and online resources have made it easier for individuals to recognize the signs of GERD, such as heartburn, regurgitation, and persistent coughing, leading to a proactive approach in seeking medical evaluation.
Reflux Testing Devices Market Analysis
When it comes to testing for stomach acid reflux, there are three main devices useda capsule, a probe, or a catheter. Experts predict that the capsule will become the most popular choice by 2032, growing at a steady rate of 5.2% each year. The capsule has been a game-changer in diagnosing heartburn (GERD). It's easy to swallow and doesn't require any uncomfortable procedures. Plus, it's super accurate and can even track how well your treatment is working in real time. As technology keeps getting better, the future of GERD management looks promising. With the help of these advanced devices, people with heartburn can expect better treatment and a better quality of life.

The reflux testing devices market by application is categorized into gastroesophageal reflux disease, surgical procedures, and others. The gastroesophageal reflux disease segment accounted for USD 2 billion revenue size in the year 2022. Globally, there were nearly 800 million GERD cases reported in 2019 as per study conducted by the Global Burden of Disease (GBD).
In Western countries, GERD is particularly common, with an estimated prevalence of 20-25%. However, it is not confined to these regions, as it increasingly affects populations in Asia, the Middle East, and Africa. Its prevalence is influenced by various factors, including lifestyle choices, obesity rates, and an aging population. However, the growing awareness of GERD and the proactive approach of healthcare providers have led to higher diagnosis rate, enabling individuals to seek timely treatment and management.
When it comes to reflux testing devices, hospitals are the big players, taking the lion's share of the market. That's because hospitals are like one-stop shops for patients, offering everything from diagnosis to treatment and even surgery if needed. They have the doctors, the equipment, and the experience to handle all aspects of reflux disease. Plus, many hospitals have close relationships with specialists, so if you need a second opinion or specialized care, you can get it without having to go to a different location. It's no wonder that hospitals are such a dominant force in the reflux testing market. And as they continue to invest in research and new technologies, their role is only going to grow more important in the future. For patients, that means having access to the best possible care and the most accurate reflux testing available.

U.S. reflux testing devices market accounted for USD 1 billion revenue size in 2022. The widespread use of reflux testing equipment is facilitated by the developed healthcare infrastructure in the U.S. and accessibility to cutting-edge technology including surgical robots, capsule endoscopy, and others. The ageing of the population and technological development both contribute to market expansion. Furthermore, the U.S.'s dominant position in the market is further cemented by significant market competitors, well-developed marketing tactics, and governmental approvals.
Reflux Testing Devices Market Share
Some of the eminent market participants operating in the reflux testing devices industry include
- Medtronic
- Biomedix
- Johnson & Johnson Services, Inc
- Diversatek, Inc.
- Laborie
- Diversatek Healthcare
- Creo Medical Group PLC
- JINSHAN Science & Technology (Group) Co., Ltd.
- Thermo Fisher Scientific
- EB Neuro S.p.A.
Reflux Testing Devices Industry News
- In April 2023, Laborie introduced the alpHaONE system, which is capable of recording data for up to 96 hours and has been developed to diagnose GERD. AlpHaONE is a patient-centered solution that enables convenient monitoring and precise, accurate data. The extensive software programme included in the alpHaONE system includes a Virtual Instruction Programme that facilitates simple navigation. A seamless user experience is further ensured by user-customizable symptom buttons and automatic pH data analysis. This launch will help the company in strengthening its product portfolio.
- In Febuary 2023, Diversatek Healthcare, Inc., acquired Group G-Flex (GFE do Brasil), a producer and distributor of single-use and reusable endoscopy tools and devices. The acquisition significantly expanded the company’s global presence and adds a wide range of goods to its portfolio. As a result of the acquisition, Diversatek Healthcare gained access to around 250 SKUs, including goods for the gastrointestinal and pulmonary niche sectors. This acquisition strategy will boost the sales and earnings of the company.
Reflux testing devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD and volume in Units from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
By Product Type (USD Million & Units)
- Reflux capsule
- Reflux probe
- Reflux catheter
By Application (USD Million)
- Gastroesophageal reflux disease
- Surgical procedures
- Others
By End-use (USD Million)
- Hospitals
- Diagnostic centers
- Ambulatory surgical centers
- Others
The above information is provided for the following regions and countries
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Switzerland
- The Netherlands
- Denmark
- Poland
- Sweden
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- New Zealand
- Thailand
- Vietnam
- Indonesia
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
- Turkey